| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.70B | -3.6% |
| Cost of Revenue | $1.49B | -20.4% |
| Gross Profit | $1.21B | +30.6% |
| R&D Expense | $304.8M | -4.3% |
| SG&A Expense | $651.0M | -18.4% |
| Operating Income | -$529.0M | +55.8% |
| Interest Expense | $4.3M | -95.6% |
| Pre-tax Income | -$552.1M | +56.1% |
| Income Tax | -$200K |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $697.6M | -14.3% |
| Accounts Receivable | $103.6M | +6.6% |
| Inventory | $329.7M | -36.9% |
| Current Assets | $1.27B | -22.8% |
| Total Assets | $2.19B | -21.1% |
| Current Liabilities | $685.2M | -10.0% |
| Long-term Debt | $1.55B | — |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.1M | +82.9% |
| Investing Cash Flow | $26.8M | +138.3% |
| Financing Cash Flow | -$94.4M | -222.9% |
| -105.4% |
| Net Income | -$551.9M | +56.3% |
| EPS (Basic) | -$1.51 | +58.5% |
| EPS (Diluted) | -$1.51 | +58.5% |
| Total Liabilities |
| $2.70B |
| -11.7% |
| Stockholders' Equity | -$519.1M | -75.9% |